ACCOUNTS - Final Accounts


Caseware UK (AP4) 2022.0.179 2022.0.179 2022-12-312022-12-312022-01-01falseNo description of principal activity128truetrue 09794982 2022-01-01 2022-12-31 09794982 2021-01-01 2021-12-31 09794982 2022-12-31 09794982 2021-12-31 09794982 1 2022-01-01 2022-12-31 09794982 d:Director2 2022-01-01 2022-12-31 09794982 d:RegisteredOffice 2022-01-01 2022-12-31 09794982 c:CurrentFinancialInstruments 2022-12-31 09794982 c:CurrentFinancialInstruments 2021-12-31 09794982 c:CurrentFinancialInstruments c:WithinOneYear 2022-12-31 09794982 c:CurrentFinancialInstruments c:WithinOneYear 2021-12-31 09794982 c:ShareCapital 2022-12-31 09794982 c:ShareCapital 2021-12-31 09794982 c:OtherMiscellaneousReserve 2022-12-31 09794982 c:OtherMiscellaneousReserve 2021-12-31 09794982 c:RetainedEarningsAccumulatedLosses 2022-12-31 09794982 c:RetainedEarningsAccumulatedLosses 2021-12-31 09794982 d:FRS102 2022-01-01 2022-12-31 09794982 d:Audited 2022-01-01 2022-12-31 09794982 d:FullAccounts 2022-01-01 2022-12-31 09794982 d:PrivateLimitedCompanyLtd 2022-01-01 2022-12-31 09794982 d:SmallCompaniesRegimeForAccounts 2022-01-01 2022-12-31 iso4217:GBP xbrli:pure
Registered number: 09794982 (England and Wales)














COMPLIANCE SCIENCE LIMITED

DIRECTOR'S REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2022


 
COMPLIANCE SCIENCE LIMITED
 

 
COMPANY INFORMATION


Director
A Kadomatsu 




Registered number
09794982



Registered office
New Penderel House
4th Floor

283-288 High Holborn

London

England

WC1V 7HP




Independent auditors 
ZEDRA Corporate Reporting Services (UK) Limited






 
COMPLIANCE SCIENCE LIMITED
 


CONTENTS



Page
Balance Sheet
 
1
Notes to the Financial Statements
 
2 - 6



 
COMPLIANCE SCIENCE LIMITED
REGISTERED NUMBER:09794982


BALANCE SHEET
AS AT 31 DECEMBER 2022

2022
2021
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
569,576
487,616

Bank and cash balances
  
1,489,931
1,137,073

  
2,059,507
1,624,689

Creditors: amounts falling due within one year
 5 
(1,878,568)
(2,046,683)

Net current assets/(liabilities)
  
 
 
180,939
 
 
(421,994)

Total assets less current liabilities
  
180,939
(421,994)

  

Net assets/(liabilities)
  
180,939
(421,994)


Capital and reserves
  

Called up share capital 
  
100
100

Capital contribution reserve
 6 
28,504
28,504

Profit and loss account
  
152,335
(450,598)

  
180,939
(421,994)


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 


A Kadomatsu
Director

Date: 29 September 2023

The notes on pages 2 to 6 form part of these financial statements.

Page 1


 
COMPLIANCE SCIENCE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

1.Accounting policies

 
1.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
1.2

Going concern

The Company is in a net asset position of £180,939, supported by a significant cash balance. There is additionally a significant amount remaining due to the parent company of £577,530.
Compliance Science Limited has received written confirmation from its parent company, Compliance Science, Inc., that it will continue to provide financial support to the Company for a period of at least 12 months from the date of signing these financial statements and will not recall the intercompany amount due until the Company has sufficient resources to repay the balance. For these reasons, the director continues to adopt the going concern basis in preparing the financial statements. 

 
1.3

Revenue

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the Company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before turnover is recognised:

Rendering of services

Turnover from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of turnover can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
1.4

Debtors

Short term debtors are measured at transaction price, less any impairment. 

 
1.5

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash held on deposit by service providers is included within bank and cash balances, as these amounts are highly liquid and repayable without penalty on notice of not more than 24 hours.

Page 2


 
COMPLIANCE SCIENCE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

1.Accounting policies (continued)

  
1.6

Creditors

Short term creditors are measured at the transaction price. Amounts owed to group undertakings are intercompany loans measured at cost. These loans are unsecured, interest free and repayable on demand.

 
1.7

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

  
1.8

Share based payments

Where share options are awarded to employees, the fair market value of the options at the date of grant is charged to profit or loss over the vesting period. Non-market vesting conditions are taken into account by adjusting the number of equity instruments expected to vest at each balance sheet date so that, ultimately, the cumulative amount recognised over the vesting period is based on the number of options that eventually vest. Market vesting conditions are factored into the fair value of the options granted. The cumulative expense is not adjusted for failure to achieve a market vesting condition. 
The fair value of the award also takes into account non-vesting conditions. These are either factors beyond the control of either party (such as target based on an index) or factors which are within the control of one or other of the parties (such as the Company keeping the scheme open or the employee maintaining any contributions required by the scheme).
Where the terms and conditions of options are modified before they vest, the increase in the fair value of the options, measured immediately before and after the modification, is also charged to profit or loss over the remaining vesting period. 

 
1.9

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Page 3


 
COMPLIANCE SCIENCE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

1.Accounting policies (continued)

 
1.10

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
1.11

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


2.


Auditors' information

The auditors' report on the financial statements for the year ended 31 December 2022 was unqualified.

The audit report was signed on 29 September 2023 by Dominic King ACA (Senior Statutory Auditor) on behalf of ZEDRA Corporate Reporting Services (UK) Limited.


3.


Employees

The average monthly number of employees, including directors, during the year was 12 (2021 - 8).

Page 4


 
COMPLIANCE SCIENCE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

4.


Debtors

2022
2021
£
£


Trade debtors
558,318
365,626

Other debtors
8,446
7,560

Prepayments and accrued income
2,594
23,355

Deferred taxation
218
91,075

569,576
487,616



5.


Creditors: Amounts falling due within one year

2022
2021
£
£

Trade creditors
2,260
2,986

Amounts owed to group undertakings
577,530
628,658

Corporation tax
57,782
-

Other taxation and social security
93,662
94,044

Other creditors
80,264
2,593

Accruals and deferred income
1,067,070
1,318,402

1,878,568
2,046,683



6.


Capital contribution reserve

Certain employees of the Company along with other group employees have been granted options and Class B units over the shares in the parent company. The options and units are granted at an independently determined fair value and vesting for these fall under two categories: 25% of the options are exerciseable on the 12 month anniversary of the vesting commencement date and then at 6.25% at the end of each third calendar month after the first vesting date, and units only vest and become exerciseable on the sale of the parent company.
In the prior year, there was a change of ownership of the parent company, and as such the units granted fully vested. An expense equivalent to the fair value of the share options and units granted is recognised over the vesting period with a corresponding amount being recognised as a capital contribution reserve.


7.


Controlling party

Compliance Science, Inc., is the parent of the smallest group for which consolidated financial statements are drawn up of which the Company is a member. The registered office of the parent company is 136 Madison Avenue, 8th Floor, New York, NY 10016. 

Page 5


 
COMPLIANCE SCIENCE LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

8.


Post balance sheet events

There were no adjusting or non-adjusting events occurring between the end of the reporting year and the date these financial statements were approved. 

 
Page 6